DE69501314D1 - Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält - Google Patents

Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält

Info

Publication number
DE69501314D1
DE69501314D1 DE69501314T DE69501314T DE69501314D1 DE 69501314 D1 DE69501314 D1 DE 69501314D1 DE 69501314 T DE69501314 T DE 69501314T DE 69501314 T DE69501314 T DE 69501314T DE 69501314 D1 DE69501314 D1 DE 69501314D1
Authority
DE
Germany
Prior art keywords
substances
pct
casein
bicarbonations
liquid containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69501314T
Other languages
English (en)
Other versions
DE69501314T2 (de
Inventor
Thomas Gilchrist
William Manson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Giltech Ltd
Original Assignee
Giltech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giltech Ltd filed Critical Giltech Ltd
Publication of DE69501314D1 publication Critical patent/DE69501314D1/de
Application granted granted Critical
Publication of DE69501314T2 publication Critical patent/DE69501314T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69501314T 1994-06-02 1995-06-02 Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält Expired - Fee Related DE69501314T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9411009A GB9411009D0 (en) 1994-06-02 1994-06-02 Dialysis fluid
PCT/GB1995/001275 WO1995033477A1 (en) 1994-06-02 1995-06-02 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents

Publications (2)

Publication Number Publication Date
DE69501314D1 true DE69501314D1 (de) 1998-02-05
DE69501314T2 DE69501314T2 (de) 1998-07-23

Family

ID=10756046

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69501314T Expired - Fee Related DE69501314T2 (de) 1994-06-02 1995-06-02 Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält

Country Status (11)

Country Link
US (1) US5780438A (de)
EP (1) EP0731711B1 (de)
JP (1) JPH10505322A (de)
CN (1) CN1153588C (de)
AT (1) ATE161424T1 (de)
AU (1) AU682609B2 (de)
CA (1) CA2191769C (de)
DE (1) DE69501314T2 (de)
ES (1) ES2114322T3 (de)
GB (1) GB9411009D0 (de)
WO (1) WO1995033477A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0958832B1 (de) 1998-05-21 2006-01-25 Nipro Corporation Albumin enthaltende Lösung für die Peritonealdialyse
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
US6770148B1 (en) * 1998-12-04 2004-08-03 Baxter International Inc. Peritoneal dialysis solution containing modified icodextrins
JP4205227B2 (ja) 1999-01-11 2009-01-07 カルピス株式会社 ペプチド含有液の精製方法
EP2052751A3 (de) * 1999-09-22 2009-06-03 Advanced Renal Technologies Anwendung eines Dialysats mit hohem Zitratgehalt
DE10114283C2 (de) * 2000-12-22 2003-04-24 Fresenius Medical Care De Gmbh Verfahren zur Ermittlung der Ionenkonzentration des Blutes eines Patienten bei der citrat-antikoagulierten Hämodialyse und/oder Hämofiltration; Dialysegerät
US7445801B2 (en) * 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US7053059B2 (en) 2003-07-25 2006-05-30 Baxter International Inc. Dialysis solutions with reduced levels of glucose degradation products
US20050148647A1 (en) * 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
KR20150028116A (ko) * 2013-09-05 2015-03-13 삼성전자주식회사 아미노산계 이온성 올리고머를 포함한 유도 용질

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521712D0 (en) * 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
DE3683583D1 (de) * 1985-09-10 1992-03-05 Res Corp Technologies Inc Osmotische mittel fuer peritonealdialyse.
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis

Also Published As

Publication number Publication date
MX9606042A (es) 1998-06-30
AU2623895A (en) 1996-01-04
WO1995033477A1 (en) 1995-12-14
JPH10505322A (ja) 1998-05-26
GB9411009D0 (en) 1994-07-20
ES2114322T3 (es) 1998-05-16
ATE161424T1 (de) 1998-01-15
CA2191769A1 (en) 1995-12-14
EP0731711A1 (de) 1996-09-18
AU682609B2 (en) 1997-10-09
US5780438A (en) 1998-07-14
CN1153588C (zh) 2004-06-16
EP0731711B1 (de) 1997-12-29
CN1150759A (zh) 1997-05-28
CA2191769C (en) 2005-03-15
DE69501314T2 (de) 1998-07-23

Similar Documents

Publication Publication Date Title
DE69501314D1 (de) Dialyseflüssigkeit, die aus casein gewonnene peptide als osmotische substanzen und bicarbonationen als buffersubstanzen enthält
WO1995021601A3 (en) Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
PT1140014E (pt) Sistema de distribuicao osmotico que possui embolo com utilizacao eficaz de espaco
NL970008I1 (nl) Derivaat van een weefselplasminogeenactivator.
DK0706378T3 (da) Ny farmaceutisk formulering.
KR950702248A (ko) 단백질을 기초로 한 전달 시스템(protein based delivery system)
EE200200510A (et) POL1212 aminohappejärjestust kodeeriv DNA, seda sisaldav ekspressioonivektor, sea modifitseeritud VIII- tegur, sellel põhinev ravimkompositsioon ningmeetod sea modifitseeritud VIII-teguri aminohappejärjestust omava valgu valmistamiseks
HUP0302304A2 (hu) Tejeredetű csontvédő kompozíciók
DE69309712D1 (de) Pharmazeutische und dermokosmetische mittel enthaltend pferdecolostrum
NO954320L (no) Lyosfærer omfattende gonadotropin
FR2837098B1 (fr) Composition cosmetique ou pharmaceutique comprenant des peptides, procedes de traitement et utilisations
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
NO972849L (no) Peptid p277 analoger og farmasöytiske sammensetninger som omfatter disse for behandling eller diagnostikk av diabetes
DE69420145D1 (de) Behandlung präkanzeröser läsionen durch muramylpeptide
ES2108694T3 (es) Inhibidor de proteasa.
DE60140493D1 (de) Verfahren zur Reinigung stark anionischer Proteine
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
ATE226591T1 (de) Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
DK0651764T3 (da) Cytotoksisk T-lymfocytantigen som cysteinproteaseinhibitor
Critical Care Society of South Africa Working Group Severe sepsis and the role of novel therapeutic agents. Position statement of the Critical Care Society of South Africa on severe sepsis and the role of novel therapeutic agents such as drotrecogin alfa (activated)
DK0688222T3 (da) Terapeutiske præparater indeholdende en lithiumforbindelse og silica
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
UA9703A (uk) Антипротеіназний засіб

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee